Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29919643 | 1.00 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15772419 | 0.95 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22325684 | 0.95 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29919785 | 0.91 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL347009 | 0.91 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11672339 | 0.89 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15772726 | 0.88 | CYP1A2 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10935020 | 0.87 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL714532 | 0.87 | KDM4E (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15772990 | 0.86 | CA12 (0.56) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | SICPA HOLDING SA (CH) | 2025-12-30 | — | — | US | disclosed |
| EP-4069806-B1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-20240327736-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2024-10-03 | — | — | US | disclosed |
| US-12031098-B2 | Method of marking a petroleum hydrocarbon | SICPA HOLDING SA (CH) | 2024-07-09 | — | — | US | disclosed |
| EP-4069807-B1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-10-04 | — | — | EP | disclosed |
| US-20230103579-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-04-06 | — | — | US | disclosed |
| US-20230029106-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2023-01-26 | — | — | US | disclosed |
| EP-4069807-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | Sicpa Holding SA (CH) | 2022-10-12 | — | — | EP | disclosed |
| WO-2021110526-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2021-06-10 | — | — | WO | disclosed |
| WO-2021110525-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2021-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | CYP4A11, CYP11B1, CYP11A1 | CA12 1347/4885CA1 2012/4885CA2 2852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.